On Friday, Mizuho maintained its Neutral stance on UiPath Inc. (NYSE: NYSE:PATH) stock, with a consistent price target of $14.00. The decision follows UiPath's second quarter revenue surpassing consensus estimates, marking a $14 million beat, an improvement from the $3 million beat in the previous quarter. The company's management credited the success to better execution amidst a fluctuating economic landscape.
UiPath also provided an updated forecast, increasing its FY25 revenue growth guidance to 9% from the previously projected 8%. This revision indicates a positive trajectory for the company's financial outlook. Mizuho acknowledged this upward adjustment as a sign of progress for UiPath.
Despite the encouraging performance and heightened expectations, some investors remain cautious. The introduction of new platform features aimed at enhancing AI and automation capabilities, including the use of generative AI and natural language processing, has not fully assuaged concerns about the long-term demand for Robotic Process Automation (RPA) in light of potential disruptions from AI advancements.
Mizuho's price target for UiPath is based on 4x next twelve months (NTM) enterprise value to revenue (EV/Rev) and 19x NTM enterprise value to free cash flow (EV/FCF), which aligns with the valuations of its industry peers. The firm's reiteration of the Neutral rating reflects a careful assessment of UiPath's current position and potential in the market.
In other recent news, UiPath Inc. has seen a series of notable developments. DA Davidson has adjusted its price target for the company to $15, maintaining a neutral stance. This revision followed UiPath's Q2 2025 results, which showcased an improvement in revenue forecasts and a significant boost to profit expectations, attributed to operational discipline and a strategic share repurchase program.
In addition, UiPath has announced significant changes to its leadership team. S. Somasegar, a seasoned technology executive, has been appointed to its Board of Directors. Ashim Gupta, a veteran within the company, has assumed the role of Chief Operating Officer while retaining his position as Chief Financial Officer.
UiPath also plans to reduce its global workforce by approximately 10% to enhance operational efficiency. The restructuring costs for this initiative are projected to range from $17 million to $25 million.
In response to these developments, several financial analyst firms have adjusted their stance on UiPath. Scotiabank and Truist Securities have maintained their ratings, while BMO Capital Markets and Macquarie have adjusted their price targets for UiPath. Canaccord Genuity has maintained a buy rating on UiPath's shares, despite reducing its price target.
InvestingPro Insights
UiPath Inc. (NYSE: PATH) has shown resilience in a challenging economic environment, as reflected in its recent quarterly revenue surpassing estimates. InvestingPro data highlights a market capitalization of $7.3 billion, with a notable revenue growth of 22.71% in the last twelve months as of Q1 2025. This growth is coupled with an impressive gross profit margin of 84.74%, illustrating the company's efficiency in maintaining profitability despite market fluctuations.
InvestingPro Tips indicate that UiPath holds more cash than debt on its balance sheet and analysts predict the company will be profitable this year, signaling a strong financial foundation and a positive outlook for future profitability. These insights suggest that UiPath's strategic initiatives in AI and automation could potentially strengthen its market position. With 9 additional InvestingPro Tips available, including a detailed analysis of the company's financial health and stock performance, investors can further explore UiPath's potential at InvestingPro.
The company's stock has experienced a significant rebound over the last month with a 16.99% return, despite a more substantial decline over the last six months. As Mizuho maintains a Neutral stance with a $14.00 price target, the InvestingPro fair value estimate stands at $14.38, slightly above Mizuho's target, suggesting a potential undervaluation of UiPath's shares. This data may provide investors with a more nuanced perspective on the company's valuation and future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.